findmyKOL

Charles Burant, MD, PhD

Basic profile

Endocrinology, Diabetes & Metabolism

ORCIDNone on fileNPI
RegionAnn Arbor, MI · MidwestSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationNot yet indexedOnline presenceNot yet checkedPaymentsNone reportedNIH funding2004–2026Why? →

Charles Burant is an Endocrinology/Metabolic physician. ClinicalTrials.gov lists 1 registered study matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)

Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials
12NIH grants · 2004–2026

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

24 Frank Lloyd Wright Dr
Lobby C Suite 1300
Ann Arbor, MI 48105

Telephone

734-998-2450

Registry record last updated 20 Nov 2019.

View the NPPES registry record

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    75.5%
    Biguanide (metformin)42.9%
    Metformin Hcl100%
    Part D<11 patients
    GLP-1 receptor agonist32.7%
    Trulicity100%
    Part D<11 patients
  • Cardiovascular

    24.5%
    ACE inhibitor24.5%
    Lisinopril100%
    Part D<11 patients
Where care is delivered (Part B), 20220% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

12 NIH research awards on record, funded 20042026 per NIH RePORTER. The latest:

95 more award records behind the reveal.Reveal →

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”